Cytogenetic polyclonality in hematologic malignancies - PubMed (original) (raw)
Affiliations
- PMID: 10451702
Cytogenetic polyclonality in hematologic malignancies
B Johansson et al. Genes Chromosomes Cancer. 1999 Mar.
Abstract
The present study was undertaken to ascertain the frequency of cytogenetic polyclonality in various hematologic malignancies and to investigate whether morphologic subgroup, age, gender, or previous genotoxic exposure influences the incidence. Among 2,243 cytogenetically investigated hematologic malignancies, 10 acute myeloid leukemias (AML), 5 myelodysplastic syndromes (MDS), 2 acute lymphoblastic leukemias (ALL), 1 acute undifferentiated leukemia (AUL), 1 atypical Philadelphia chromosome-negative (Ph-) chronic myeloid leukemia (CML), 1 chronic myeloproliferative disorder (CMD), and 1 chronic lymphoproliferative disorder (CLD) with karyotypically unrelated clones were identified, constituting 2.6% of AML, 1.6% of MDS, 0.8% of ALL, 13% of AUL, 9.1% of Ph- CML, 1.5% of CMD, and 2.8% of CLD with chromosomal abnormalities. In contrast to the cytogenetic features, the X-inactivation pattern was monoclonal in the two informative female patients that could be investigated. Among 17,733 karyotypically aberrant published cases surveyed, significant frequency differences (P < 0.001) were discerned: 1.7% of 6,526 AML, 3.4% of 2,391 MDS, 0.4% of 1,920 Ph+ CML, 2.9% of 856 CMD, 0.9% of 4,226 ALL, and 5.8% of 1,814 CLD displayed unrelated clones. The incidence of cytogenetic polyclonality did not differ significantly among the MDS, CMD, or ALL subgroups, between males and females, between children (< 16 years) and adults, or between B- and T-cell ALL, whereas the frequencies varied among the AML FAB types (P < 0.05), among the different CLD entities (P < 0.001), and between B- and T-cell CLD (P < 0.001). Furthermore, the incidence was higher in therapy-related AML and MDS than in de novo AML and MDS (P < 0.001 and P < 0.01, respectively).
Similar articles
- Deletion of chromosome arm 3p in hematologic malignancies.
Johansson B, Billström R, Kristoffersson U, Akerman M, Garwicz S, Ahlgren T, Malm C, Mitelman F. Johansson B, et al. Leukemia. 1997 Aug;11(8):1207-13. doi: 10.1038/sj.leu.2400718. Leukemia. 1997. PMID: 9264371 - [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
Zhu Y, Xu W, Liu Q, Pan J, Qiu H, Wang R, Qiao C, Jiang Y, Zhang S, Fan L, Zhang J, Shen Y, Xue Y, Li J. Zhu Y, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Oct;25(5):579-82. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008. PMID: 18841577 Chinese. - Molecular cytogenetic aspects of hematological malignancies: clinical implications.
Chen Z, Sandberg AA. Chen Z, et al. Am J Med Genet. 2002 Oct 30;115(3):130-41. doi: 10.1002/ajmg.10689. Am J Med Genet. 2002. PMID: 12407693 Review. - Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
Larson RA. Larson RA. Best Pract Res Clin Haematol. 2007 Mar;20(1):29-37. doi: 10.1016/j.beha.2006.10.006. Best Pract Res Clin Haematol. 2007. PMID: 17336252 Review.
Cited by
- FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome.
Lahortiga I, Vázquez I, Belloni E, Román JP, Gasparini P, Novo FJ, Zudaire I, Pelicci PG, Hernández JM, Calasanz MJ, Odero MD. Lahortiga I, et al. Hum Genet. 2005 May;116(6):476-85. doi: 10.1007/s00439-005-1268-1. Epub 2005 Mar 3. Hum Genet. 2005. PMID: 15744521 - Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to Chemotherapy.
Kasahara K, Onozawa M, Miyashita N, Yokohata E, Yoshida M, Kanaya M, Kosugi-Kanaya M, Takemura R, Takahashi S, Sugita J, Shigematsu A, Takahata M, Fujisawa S, Hashimoto D, Fujimoto K, Endo T, Kondo T, Teshima T. Kasahara K, et al. Case Rep Hematol. 2016;2016:2373902. doi: 10.1155/2016/2373902. Epub 2016 Mar 10. Case Rep Hematol. 2016. PMID: 27034857 Free PMC article. - Niche contributions to oncogenesis: emerging concepts and implications for the hematopoietic system.
Raaijmakers MH. Raaijmakers MH. Haematologica. 2011 Jul;96(7):1041-8. doi: 10.3324/haematol.2010.028035. Epub 2011 Apr 1. Haematologica. 2011. PMID: 21459792 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous